Dr. Dixon Advises Against Mastectomies

J. Michael Dixon, MD
Published: Thursday, Apr 26, 2012

J. Michael Dixon, MBChB, MD, Professor of Surgery, Consultant Surgeon, University of Edinburgh, Clinical Director of the Edinburgh Breast Unit, Western General Hospital, Edinburgh, Scotland, discusses the need to develop a better way of informing women with breast cancer of the potential risks entailed by a mastectomy, including mastectomy with breast reconstruction.

Dixon explains, in the UK approximately 10% of women receiving breast reconstruction following mastectomy experienced a complication that resulted in the loss of their implant. Readmission following mastectomy reaches 10-20%, he notes, this number is exceptionally high when you consider the procedure has not been associated with a reduced rate of local recurrence.

The need for education is an ongoing item, as is the need to increase awareness in the US. Dixon notes, there is currently a large disparity between the UK and the US. He adds that more women in the US are needlessly receiving mastectomy causing additional risks when breast-conserving surgery is the better option.
 
J. Michael Dixon, MBChB, MD, Professor of Surgery, Consultant Surgeon, University of Edinburgh, Clinical Director of the Edinburgh Breast Unit, Western General Hospital, Edinburgh, Scotland, discusses the need to develop a better way of informing women with breast cancer of the potential risks entailed by a mastectomy, including mastectomy with breast reconstruction.

Dixon explains, in the UK approximately 10% of women receiving breast reconstruction following mastectomy experienced a complication that resulted in the loss of their implant. Readmission following mastectomy reaches 10-20%, he notes, this number is exceptionally high when you consider the procedure has not been associated with a reduced rate of local recurrence.

The need for education is an ongoing item, as is the need to increase awareness in the US. Dixon notes, there is currently a large disparity between the UK and the US. He adds that more women in the US are needlessly receiving mastectomy causing additional risks when breast-conserving surgery is the better option.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Leveraging New Evidence in the Context of Evolving Early-Stage Treatment Standards in HER2-Positive Breast CancerJan 30, 20181.5
14th Annual School of Breast Oncology® OnlineFeb 10, 201825
Publication Bottom Border
Border Publication
x